サインイン 無料でサインアップします。

Adaptimmune Therapeutics Plcの収益YQ/Q

Adaptimmune Therapeutics Plcの収益YQ/Qは何ですか。

Adaptimmune Therapeutics Plcの収益YQ/Qは2,399.63%です。

収益YQ/Qの定義は何ですか。

四半期収益成長率、前年比は、前年同期の業績と比較して、売上高の増加率がパーセンテージとして表されています。

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

NASDAQのセクタHealth Careにおける収益YQ/Qの企業と比べるAdaptimmune Therapeutics Plc

Adaptimmune Therapeutics Plcは何をしますか。

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

Adaptimmune Therapeutics Plcと類似の収益yq/q